Items Tagged ‘Richard Weinshilboum’
November 6, 2018
This article originally appeared on the Center for Individualized Medicine blog on Oct. 23, 2018. Mayo Clinic research is bringing together knowledge of psychiatry, genetics, metabolomics, pharmacogenomics and artificial intelligence to seek biological markers associated with alcohol use disorder and treatment response. Finding the molecular drivers of alcohol use disorder commonly known as alcoholism, could […]
Tags: Center for Individualized Medicine, Mark Frye, pharmacogenomics, Richard Weinshilboum
September 17, 2018
CIMCON18 — How genomics discovery is transforming individualized care and the path forward
This article originally appeared on the Center for Individualized Medicine blog on Sept. 17, 2018. Article by Sharon Rosen Mining information deeper than genomics, understanding factors linked to disease, analyzing big data, and addressing the challenges of bringing all this information together to advance patient care – these were some of the themes featured at […]
Tags: All of Us, Center for Individualized Medicine, Eric Green, Individualizing Medicine Conference, Keith Stewart, Richard Weinshilboum
August 14, 2018
Research suggests genetics are key in treating night sweats
By Advancing the Science contributor 
This post originally was published on the Center for Individualized Medicine blog on June 25, 2018 Article by Heather Carlson Women going through menopause know all too well the discomfort associated with night sweats. Hormone therapy is often used to prevent night sweats. But finding the right dose of estrogen can be tricky, with some […]
Tags: Ann Moyer, Center for Individualized Medicine, genomics, menopause, pharmacogenomics, Richard Weinshilboum, Virginia Miller, women's health
May 24, 2018
Mayo’s RIGHT 10K – moving pharmacogenomics into everyday clinical practice
This article originally appeared on the Center for Individualized Medicine blog on March 20, 2018. By Sharon Rosen After nearly half a century of research, Mayo Clinic is a leader in moving pharmacogenomics into clinical practice. This year pharmacogenomics test results for 10,000 Mayo Clinic patients, all participants in the RIGHT 10K study, are being added […]
Tags: biobank, Center for Individualized Medicine, DNA testing, genetics, Paul Takahashi, pharmacogenomics, Richard Weinshilboum